drug design
important drug targets
discovery of fragment ligands
early drug discovery process
fragment-based lead discovery
peptide-GPCRs
difficult targets
project
Computational design of GPCR drugs
new methods
binding GPCRs
promises of FBLD
computational structure-based methods
access
fragment complexes
modelling of GPCR
GPCR structural biology
computational platform
ligands of peptide
modulation of multiple targets
successful use of FBLD
existing methods
novel lead candidates
important roles
atomic resolution
new pharmaceuticals
biophysical screening
atomic level
neurological diseases
novel strategies
difficult problems
structural information
sensitive screening assays
knowledge of receptor function
predictive models of receptor
efficient treatment of neurological disorders
fragments
opportunities
numerous physiological processes
technological advances
industry struggles
goal
ligand interactions
receptors
optimization
address
vision
Jigsaw puzzles
powerful approach
molecular docking
Breakthroughs
challenge
G protein
potent leads
research
techniques
objective
focus